Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

Egypt. J. Exp. Biol. (Bot.). 2010; 6(2): 177-182


THE IN VITRO EVALUATION OF ANTIBACTERIAL AGENTíS ACTIVITY AGAINST URINARY TRACT INFECTIONS ISOLATES

Mohamed Samhan Ahmed Badri.

Abstract
Activity of ten different antibacterial agents commonly used in treatment of urinary tract infections (UTI) at AL-Batnan Medical Centre, Tobruq-Libya was studied against 8 different bacterial species isolated from 718 UTI patients, during 2004 - 2008. The study of the antibacterial sensitivity / resistance pattern indicated that UTI caused by (E. coli , Klebsiella pneumoniae, Staphyloccus epidermidis ,Staphyloccus aureus , Proteus mirabilis) isolates showed relatively a high to moderate rate of sensitivity to ciprofloxacin (77.6%) , amoxicillin (67.7%), nitrofurantoin (65.9%) and ceftrixone (58.5%). While Enterococcus faecalis isolates showed sensitivity to amoxicillin (70.2%), naldixic acid (60.3%) with a low rate of sensitivity to ampicillin (9.2%). The drug of choice to the Pseudomonas aeruginosa isolates was ciprofloxacin which revealed (87.5% sensitivity), while the other antibacterial agents failed completely or succeeded with low percentage in inhibition of Pseudomonas aeruginosa isolates growth. The study also revealed a noticeable increase in UTIs between 2004 and 2008 with a high rate of infections in children and females, with a prevalence of E. coli as a most common causative agent of UTI.

Key words: Antibacterial agents, sensitivity tests, urinary tract infections isolates



Share this Article


Advertisement
Journal of Molecular Pathophysiology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMedģ Information Services.
Scopemed Buttons